One of my favorite stem cell scientists is Jeanne Loring of Scripps. She does great science and when you ask her questions, she frankly states her opinions and is clearly a gifted educator at heart too. Below is a Q&A interview I did with Jeanne on key issues of clinical translation of iPS cells. You […]
Jeanne Loring interview: optimism on clinical translation of IPS cells Read More »
One of the more exciting stem cell biotechs out there today is Advanced Cell Technology (ACT). At this time ACT has the only two ES cell-based FDA-approved clinical trials ongoing and so far they have looked quite promising in terms of preliminary safety data. However, ACT has much more in the pipeline including potentially iPS
Interview with Gary Rabin of Advanced Cell Technology (ACT) Read More »
One of the questions I get asked most often is whether induced pluripotent stem cells (iPS cells) are well on their way to replacing ES (embryonic stem) cells. My answer? No. Not yet. iPS cells are great, but the original notion pushed by some that iPS cells would somehow replace ES cells, which would be
Primary challenges facing iPS cells in late 2012 Read More »